Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Fluorescein sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein sodium stain (substance) |
Inferred relationship |
Some |
|
Fluorescein sodium 1mg ophthalmic applicator strip |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein sodium stain (substance) |
Inferred relationship |
Some |
|
Fluorescein sodium 2% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein sodium stain (substance) |
Inferred relationship |
Some |
|
Fluorescein sodium 1% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein sodium stain (substance) |
Inferred relationship |
Some |
|
Fluorescein sodium 200mg/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein sodium stain (substance) |
Inferred relationship |
Some |
|
Fluorescein sodium 0.6mg ophthalmic strip |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein sodium stain (substance) |
Inferred relationship |
Some |
|
Fluorescein sodium 10% injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein sodium stain (substance) |
Inferred relationship |
Some |
|
Fluorescein sodium 25% injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein sodium stain (substance) |
Inferred relationship |
Some |
|
Fluorescein sodium and oxybuprocaine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein sodium stain (substance) |
Inferred relationship |
Some |
|
Benoxinate hydrochloride+fluorescein sodium 0.3%/0.125% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein sodium stain (substance) |
Inferred relationship |
Some |
|
Benoxinate hydrochloride+fluorescein sodium 0.4%/0.25% ophthalmic solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein sodium stain (substance) |
Inferred relationship |
Some |
|
Fluorescein sodium 10% intraocular injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein sodium stain (substance) |
Inferred relationship |
Some |
|
Fluorescein sodium 10% intraocular injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein sodium stain (substance) |
Inferred relationship |
Some |
|
Fluorescein sodium 25% injection solution 3mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein sodium stain (substance) |
Inferred relationship |
Some |
|
Fluorescein sodium 25% injection solution 2mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein sodium stain (substance) |
Inferred relationship |
Some |
|
Proxymetacaine hydrochloride+fluorescein sodium 0.5%/0.25% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein sodium stain (substance) |
Inferred relationship |
Some |
|
Fluorescein sodium stain method (procedure) |
Direct substance |
False |
Fluorescein sodium stain (substance) |
Inferred relationship |
Some |
|
Lidocaine hydrochloride+fluorescein sodium 4%/0.25% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein sodium stain (substance) |
Inferred relationship |
Some |
|
Fluorescein sodium stain method (procedure) |
Using substance (attribute) |
True |
Fluorescein sodium stain (substance) |
Inferred relationship |
Some |
1 |
Fluorescein sodium 1mg conventional release ophthalmic strip |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein sodium stain (substance) |
Inferred relationship |
Some |
|
Fluorescein sodium 1% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein sodium stain (substance) |
Inferred relationship |
Some |
|
Fluorescein sodium 2% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein sodium stain (substance) |
Inferred relationship |
Some |
|
Proxymetacaine hydrochloride+fluorescein sodium 0.5%/0.25% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein sodium stain (substance) |
Inferred relationship |
Some |
|
Lidocaine hydrochloride+fluorescein sodium 4%/0.25% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein sodium stain (substance) |
Inferred relationship |
Some |
|
Product containing precisely fluorescein sodium stain 2.5 milligram/1 milliliter and proxymetacaine hydrochloride 5 milligram/1 milliliter conventional release eye solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fluorescein sodium stain (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fluorescein sodium stain 2.5 milligram/1 milliliter and proxymetacaine hydrochloride 5 milligram/1 milliliter conventional release eye solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fluorescein sodium stain (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fluorescein sodium 20 milligram/1 milliliter conventional release solution for eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Fluorescein sodium stain (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fluorescein sodium 20 milligram/1 milliliter conventional release solution for eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Fluorescein sodium stain (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fluorescein sodium 20 milligram/1 milliliter conventional release eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fluorescein sodium stain (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fluorescein sodium 20 milligram/1 milliliter conventional release eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fluorescein sodium stain (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fluorescein sodium 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fluorescein sodium stain (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fluorescein sodium 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fluorescein sodium stain (substance) |
Inferred relationship |
Some |
1 |